Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 11
Submit an article Journal homepage
375
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation

Kathrin Strasser-WeipplDepartment of Medicine I, Center of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria
&
Heinz LudwigDepartment of Medicine I, Center of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, AustriaCorrespondence[email protected]
Pages 2520-2524 | Received 26 Nov 2013, Accepted 29 Jan 2014, Published online: 18 Mar 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wenjian Guo, Aishu Dong, Muqing He, Xiaoji Lin, Rongxing Yao, Baolin Zhu, Xiahui Pan & Jin Jie. (2016) A Meta-Analysis for Effects of Elevated Pre-Transplantation Serum Ferritin on the Outcomes in Patients Undergoing Hematopoietic Stem Cell Transplantation. Cancer Investigation 34:7, pages 340-347.
Read now
Avichai Shimoni. (2014) Risk stratification of patients with multiple myeloma prior to autologous stem cell transplant: what is the role of serum ferritin levels?. Leukemia & Lymphoma 55:11, pages 2419-2420.
Read now

Articles from other publishers (10)

Ayşe Uysal, Mehmet Ali Erkurt, İrfan Kuku, Emin Kaya, Ahmet Sarıcı, İlhami Berber, Soykan Biçim, Emine Hidayet, Ahmet Kaya, Süleyman Arslan & Salih Cırık. (2023) Does ferritin level affect the outcomes of autologous stem cell transplantation equally in all diseases?. Transfusion and Apheresis Science 62:3, pages 103655.
Crossref
Jiasi Zhang, Yuxi Liu, Qun Li, Aoshuang Xu, Yu Hu & Chunyan Sun. (2022) Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism. Biomedicine & Pharmacotherapy 148, pages 112747.
Crossref
Yanqing Zhang, Jiaqi Pan, Xi Chen, Lianjie Wang, Liyan Chen, Yaoyao Tian & Wei Wang. (2021) Dynamic monitoring of serum ferritin as an adverse prognostic biomarker in patients with multiple myeloma. Biomarkers in Medicine 15:16, pages 1541-1551.
Crossref
Feifei Yang, Zhaoxian Wu, Dan Dai, Lei Zhang, Xiuqun Zhang, Xuezhong Zhang & Yanli Xu. (2021) The iron chelator deferoxamine decreases myeloma cell survival. Journal of International Medical Research 49:1, pages 030006052098739.
Crossref
Babaeva T.N., Seregina O.B. & Pospelova T.I.. (2020) PREDICTIVE SIGNIFICANCE OF HIGH SERUM FERRITIN LEVELS IN THE DEBUT OF MALIGNANT LYMPHOMA. "Medical & pharmaceutical journal "Pulse", pages 74-81.
Crossref
Ying Chen, Zhimin Fan, Ye Yang & Chunyan Gu. (2019) Iron metabolism and its contribution to cancer (Review). International Journal of Oncology.
Crossref
Quan-Guang Ren, Sheng-Li Yang, Pin-Dong Li, Jin-Rong Xiong, Xiefan Fang, Jian-Li Hu, Qiu-Shuang Wang, Ren-Wang Chen, Ye-Shan Chen, Lu Wen & Miao Peng. (2017) Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients. Oncology Reports 38:5, pages 2852-2858.
Crossref
Yusuke Kamihara, Kohichi Takada, Tsutomu Sato, Yutaka Kawano, Kazuyuki Murase, Yohei Arihara, Shohei Kikuchi, Naotaka Hayasaka, Makoto Usami, Satoshi Iyama, Koji Miyanishi, Yasushi Sato, Masayoshi Kobune & Junji Kato. (2016) The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma. Oncotarget 7:39, pages 64330-64341.
Crossref
Cheolsu Kim, Ho Sup Lee, Chang-Ki Min, Je Jung Lee, Kihyun Kim, Dok Hyun Yoon, Hyeon Seok Eom, Hyewon Lee, Won Sik Lee, Ho-Jin Shin, Ji Hyun Lee, Yong Park, Jae-Cheol Jo, Young Rok Do & Yeung-Chul Mun. (2015) The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea. The Korean Journal of Internal Medicine 30:5, pages 675-683.
Crossref
Diego A. Adrianzen Herrera, Matthew Scott & Mala Varma. (2015) Myelomatous Pleural Effusion Presenting with Extreme Hyperferritinemia and Severe Inflammatory Response. Case Reports in Oncology 8:2, pages 349-355.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.